TREA

97618260 - CSL PLASMA

Follow

Information

  • Trademark
  • 97618260
  • Serial Number
    97618260
  • Filing Date
    October 04, 2022
    2 years ago
  • Transaction Date
    January 27, 2025
    a month ago
  • Status Date
    July 29, 2024
    7 months ago
  • Published for Opposition Date
    January 02, 2024
    a year ago
  • Location Date
    February 27, 2024
    a year ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LEVINE, HOWARD
  • Attorney Docket Number
    034845.091B
    Attorney Name
    Scott D. Woldow
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CSL PLASMA
Case File Statements
  • GS0411: Education services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Education services, namely, providing classes, seminars, and workshops in the field of blood plasma, donation of blood plasma and blood plasma conditions; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Educational services, namely, providing online instruction in the field of blood plasma and blood plasma conditions via an online website; Non-downloadable electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment; Non-downloadable electronic publications, namely, newsletters in the field of blood plasma and blood plasma conditions
  • GS0401: Treatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma
  • GS0361: Insurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications, medical treatment, and access to care; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial assistance programs to appropriate patients
  • GS0351: Promoting public awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnesses; Promoting public awareness of blood plasma donation; Promoting the donation of blood and volunteer services and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs; Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance
  • DS0000: "PLASMA"
  • GS0421: Medical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; new product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals and blood plasma; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Providing medical and scientific research information in the field of pharmaceuticals and blood plasma; Providing scientific information in the field of health care developments, blood plasma conditions, and new medical therapies; scientific information services in the field of health care developments, blood plasma conditions, and new medical therapies provided via the Internet; providing research information on donation of human blood for medical research
Case File Event Statements
  • 10/7/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/20/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/19/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/26/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/26/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/26/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/25/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/25/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/26/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/28/2023 - a year ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/28/2023 - a year ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/28/2023 - a year ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/28/2023 - a year ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/28/2023 - a year ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/13/2023 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/2/2024 - a year ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/2/2024 - a year ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/27/2024 - a year ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/29/2024 - 7 months ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/29/2024 - 7 months ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/29/2024 - 7 months ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/29/2024 - 7 months ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/27/2025 - a month ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT